We are live on ! Find out more
VFA

Values First Advisors Portfolio holdings

AUM $219M
1-Year Est. Return 33.32%
This Fund
S&P 500
This Quarter Est. Return
+2.57%
1 Year Est. Return
+33.32%
3 Year Est. Return
+86.41%
5 Year Est. Return
+103.88%
10 Year Est. Return
AUM
$182M
AUM Growth
-$2.71M
Cap. Flow
+$874K
Cap. Flow %
0.48%
Top 10 Hldgs %
29.39%
Holding
305
New
32
Increased
91
Reduced
92
Closed
81

Sector Composition

Rank Sector Weight
1 Miscellaneous 29.63%
2 Healthcare 15.62%
3 Technology 14.47%
4 Industrials 10.33%
5 Consumer Discretionary 6.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTGC icon
251
First Trust Global Tactical Commodity Strategy Fund
FTGC
$3.32B
-1,943
Closed -$46K
GERN icon
252
Geron
GERN
$867M
-30,674
Closed -$139K
GKOS icon
253
Glaukos
GKOS
$9.87B
-191
Closed -$24.8K
GPI icon
254
Group 1 Automotive
GPI
$3.32B
-278
Closed -$106K
GRID
255
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund
GRID
$12B
-439
Closed -$55.9K
IDYA icon
256
IDEAYA Biosciences
IDYA
$3.63B
-2,345
Closed -$74.3K
IDXX icon
257
Idexx Laboratories
IDXX
$39.8B
-2,324
Closed -$1.17M
IEX icon
258
IDEX
IEX
$16.5B
-455
Closed -$97.6K
INSP icon
259
Inspire Medical Systems
INSP
$2.11B
-431
Closed -$90.9K
INZY
260
DELISTED
Inozyme Pharma
INZY
-14,695
Closed -$76.9K
KROS icon
261
Keros Therapeutics
KROS
$220M
-1,528
Closed -$88.7K
KRYS icon
262
Krystal Biotech
KRYS
$10.3B
-292
Closed -$53.1K
KYMR icon
263
Kymera Therapeutics
KYMR
$9.56B
-1,296
Closed -$61.3K
LXEO icon
264
Lexeo Therapeutics
LXEO
$349M
-7,446
Closed -$67.3K
MSCI icon
265
MSCI
MSCI
$40.3B
-227
Closed -$133K
NKTR icon
266
Nektar Therapeutics
NKTR
$2.38B
-2,984
Closed -$58.2K
NTAP icon
267
NetApp
NTAP
$39.1B
-652
Closed -$80.5K
NTLA icon
268
Intellia Therapeutics
NTLA
$1.65B
-2,617
Closed -$53.8K
NVT icon
269
nVent Electric
NVT
$26.3B
-4,200
Closed -$295K
PCVX icon
270
Vaxcyte
PCVX
$8.85B
-1,527
Closed -$174K
PNR icon
271
Pentair
PNR
$9.03B
-1,820
Closed -$178K
POOL icon
272
Pool Corp
POOL
$6.29B
-1,599
Closed -$603K
PRCT icon
273
Procept Biorobotics
PRCT
$1.17B
-343
Closed -$27.5K
PRVA icon
274
Privia Health
PRVA
$2.61B
-4,569
Closed -$83.2K
RARE icon
275
Ultragenyx Pharmaceutical
RARE
$1.41B
-1,010
Closed -$56.1K

Similar funds

Values First Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Values First Advisors held 305 positions worth $182M, down 1.5% from $184M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Values First Advisors's Q4 2024 filing shows 32 new, 91 increased, 92 reduced and 81 closed positions. Its largest new stake was GE Vernova: 1,949 shares worth $641K. The largest sale was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $1.73M.

By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Technology.

  • Values First Advisors's largest Q4 2024 buy was GE Vernova: 1,949 shares worth $641K.
  • Values First Advisors added most to iShares 1-3 Year Treasury Bond ETF in Q4 2024, an estimated $2.31M increase.
  • Values First Advisors's biggest Q4 2024 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $1.73M.
  • Values First Advisors fully exited Idexx Laboratories in Q4 2024, selling an estimated $1.17M.
  • Values First Advisors's ten largest holdings make up 29% of its $182M portfolio in Q4 2024.
  • Values First Advisors opened 32 new positions and closed 81 in Q4 2024.
  • Values First Advisors's portfolio value fell 1.5% quarter-over-quarter to $182M.

Based on Values First Advisors's 13F filing for Q4 2024, filed 29 Jan 2025.